FDA inspection
Triumph Pharmaceuticals Inc.: FDA inspection ending Apr 29, 2025
FDA inspection 1268212 · Voluntary Action Indicated (VAI) · Saint Louis, MO
Key facts
| Inspection ID | 1268212 |
|---|---|
| Firm | Triumph Pharmaceuticals Inc. |
| FEI number | 3014539253 |
| Address | 12312 Olive Blvd Ste 250 |
| City | Saint Louis |
| State | MO |
| ZIP | 63141 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Apr 29, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data